InvestorsObserver is giving C4 Therapeutics Inc (CCCC) an Analyst Rating Rank of 26, meaning CCCC is ranked higher by analysts than 26% of stocks. The average price target for CCCC is $17.909 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating CCCC a Buy today. Find out what this means to you and get the rest of the rankings on CCCC!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With C4 Therapeutics Inc Stock Today?
C4 Therapeutics Inc (CCCC) stock is trading at $1.57 as of 9:57 AM on Monday, Oct 9, a loss of -$0.14, or -8.19% from the previous closing price of $1.71. The stock has traded between $1.55 and $1.78 so far today. Volume today is less active than usual. So far 48,178 shares have traded compared to average volume of 441,277 shares.
Click Here to get the full Stock Report for C4 Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
